Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

NCT00165568 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Neoplasm Metastasis

Interventions

DRUG: Bevacizumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]